A new review found little high-quality evidence for the management of hand–foot skin reaction (HFSR) associated with regorafenib (Stivarga, Bayer), so the study authors prepared expert advice for ...
Classic or simplified LV5FU2 regimen: Multivariate analysis from a phase III study in metastatic colorectal cancer in elderly patients. Prolonged (PI) vs short-term irinotecan (STI) administration: ...
Sex differences in toxicities and survival outcomes among patients with stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of four randomized controlled ...
Hand–foot–skin reaction (HFSR) is an adverse event frequently observed during treatment with capecitabine (cape). In the present analysis, we sought to evaluate the potential association of HFSR and ...
Acitretin (Soriatane) may improve outcomes for cancer patients with multikinase inhibitor (MKI)-mediated hand-foot skin reaction (HFSR), according to a small retrospective study. Of eight MKI users ...
An extensive literature review has found that side effects from regorafenib like redness and swelling may be undertreated. Also included in this study are recommendations from experienced oncologists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results